A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.

Clinical trial NCT00638742 · COMPLETED

Trial details

NCT number: NCT00638742
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glaucoma Ocular Hypertension

Start date: 2008-05-01
Primary completion: 2009-03-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.